Heineken has agreed to acquire five beer and cider brands from Asahi Beverages, in a deal which will satisfy the conditions for Asahi’s purchase of Carlton & United Breweries (CUB).
Asahi put the brands up for sale as a condition from Australia’s competition watchdog, ACCC, for its acquisition of CUB.
ACCC approved AB InBev’s proposed sale of CUB to Asahi for $11 billion earlier this year, with the condition that Asahi offloaded certain brands to prevent reduced competition in the cider and beer market.
The deal will see Strongbow Australia reunite with its global Strongbow portfolio after 17 years, when Heineken bought the rights to the entire brand outside of Australia and New Zealand.
Following its successful bid, Heineken will also take ownership of Little Green and Bonamy’s, along with the Australian rights to international beer brands, Stella Artois and Beck’s.
Following completion of the deal, the five brands will be distributed in Australia by Drinkworks, a wholly-owned subsidiary of Heineken, strengthening its existing portfolio in the country that includes Tiger, Sol and Orchard Thieves.
Jacco van der Linden, president of Heineken APAC, said: “We are thrilled to bring the Strongbow brand in Australia home to Heineken and scale up our beer and cider portfolio in one of the world’s leading beer and cider markets.
“This acquisition shows that Heineken remains active in pursuing growth where we see opportunities that align with our long-term strategy.”
According to Asahi, there will be no manufacturing job losses or brewery closures as a result of the deal.
The deal remains subject to regulatory approval – including the ACCC – which is expected in Q4 2020. No financial details were disclosed.
By Emma Upshall
Source: foodbev.com
Free-from is becoming much more mainstream, moving beyond food allergens and intolerances. While it’s still vital to innovate products for lactose intolerance, gluten allergies and so forth, the umbrella term of free-from has taken on many different meanings.
Arla Foods Ingredients (AFI) is targeting infant formula, sports nutrition and medical nutrition with its new patented milk fractionation technology that separates milk proteins from whey, bypassing the need to make cheese. The Denmark-based company says this move enables scientists, nutritionists and health professionals to create “next-generation” dairy products.
Located in Ma’anshan, Anhui province, the facility has the potential to produce an estimated 150 million litres of oat-based products annually at full capacity. The opening comes just a few months after Oatly – which claims to have established a new Chinese character for ‘plant-based milk’ – inaugurated its first Asian factory in Singapore.
